Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey (CROSBI ID 306941)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

(BALKAN-AF Investigators) Potpara, Tatjana S. ; The BALKAN-AF Investigators ; Dan, Gheorghe-Andrei ; Trendafilova, Elina ; Goda, Artan ; Kusljugic, Zumreta ; Manola, Sime ; Music, Ljilja ; Musetescu, Rodica ; Badila, Elisabeta et al. Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey // Scientific reports, 6 (2016), 1; 1-10. doi: 10.1038/srep20432

Podaci o odgovornosti

Potpara, Tatjana S. ; The BALKAN-AF Investigators ; Dan, Gheorghe-Andrei ; Trendafilova, Elina ; Goda, Artan ; Kusljugic, Zumreta ; Manola, Sime ; Music, Ljilja ; Musetescu, Rodica ; Badila, Elisabeta ; Mitic, Gorana ; Paparisto, Vilma ; Dimitrova, Elena S. ; Polovina, Marija M. ; Petranov, Stanislav L. ; Djergo, Hortensia ; Loncar, Daniela ; Bijedic, Amira ; Brusich, Sandro ; Lip, Gregory Y. H.

BALKAN-AF Investigators

engleski

Stroke prevention in atrial fibrillation and ‘real world’ adherence to guidelines in the Balkan Region: The BALKAN-AF Survey

Data on the management of atrial fibrillation (AF) in the Balkan Region are limited. The Serbian AF Association (SAFA) prospectively investigated contemporary 'real-world' AF management in clinical practice in Albania, Bosnia&Herzegovina, Bulgaria, Croatia, Montenegro, Romania and Serbia through a 14-week (December 2014-February 2015) prospective, multicentre survey of consecutive AF patients. We report the results pertinent to stroke prevention strategies. Of 2712 enrolled patients, 2663 (98.2%) with complete data were included in this analysis (mean age 69.1 ± 10.9 years, female 44.6%). Overall, 1960 patients (73.6%) received oral anticoagulants (OAC) and 762 (28.6%) received antiplatelet drugs. Of patients given OAC, 17.2% received non-vitamin K antagonist oral anticoagulants (NOACs). CHA2DS2-VASc score was not significantly associated with OAC use. Of the 'truly low-risk' patients (CHA2DS2-VASc = 0 [males], or 1 [females]) 56.5% received OAC. Time in Therapeutic Range (TTR) was available in only 18.7% of patients (mean TTR: 49.5% ± 22.3%). Age ≥ 80 years, prior myocardial infarction and paroxysmal AF were independent predictors of OAC non-use. Our survey shows a relatively high overall use of OAC in AF patients, but with low quality of vitamin K antagonist therapy and insufficient adherence to AF guidelines. Additional efforts are needed to improve AF- related thromboprophylaxis in clinical practice in the Balkan Region.

Atrial fibrillation ; Health Surveys ; Practice Guidelines ; Stroke

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

6 (1)

2016.

1-10

objavljeno

2045-2322

10.1038/srep20432

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost